NMLSF (Restart Life Sciences) ROE % Adjusted to Book Value : Negative Equity% (As of Sep. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Restart Life Sciences ROE % Adjusted to Book Value?

Restart Life Sciences's ROE % for the quarter that ended in Sep. 2024 was Negative Equity. Restart Life Sciences's PB Ratio for the quarter that ended in Sep. 2024 was N/A. Restart Life Sciences's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was Negative Equity.

Restart Life Sciences ROE % Adjusted to Book Value Historical Data

The historical data trend for Restart Life Sciences's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Restart Life Sciences ROE % Adjusted to Book Value Chart

Restart Life Sciences Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-41.37

-18.86

-64.13

-12.93

-2.67

Restart Life Sciences Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-	-	-	-	Negative Equity

Competitive Comparison of Restart Life Sciences's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Restart Life Sciences's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Restart Life Sciences's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Restart Life Sciences's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Restart Life Sciences's ROE % Adjusted to Book Value falls into.

Restart Life Sciences ROE % Adjusted to Book Value Calculation

Restart Life Sciences's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2022 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-933.16%	/	350.00
	=	-2.67%

Restart Life Sciences's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	Negative Equity	/	N/A
	=	Negative Equity

Restart Life Sciences ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Restart Life Sciences's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Restart Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Restart Life Sciences Corp (OTCPK:NMLSF) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

HN30:Germany HEAL:Canada

Address

700-838 West Hastings St, Vancouver, BC, CAN, V6C 0A6

Website

https://www.restartlife.co

Restart Life Sciences Corp is a Canadian life sciences company dedicated to addressing today's health challenges with wellness solutions. It is focus is on creating health foods that address the needs of this community. Its Flagship developments includes Autism Spectrum, Health-Related Foods, Psilocybin Clinical Trial for Fragile X Syndrome, Orphan Drug Designation (FDA and EMA).